MannKind Corporation

Direct answer

MannKind Corporation is publicly traded on NASDAQ under the ticker MNKD.

MannKind Corporation operates as a biopharmaceutical firm, primarily focused on innovating and bringing to market respiratory-delivered treatments. Its efforts are directed towards tackling endocrine system disorders and rare lung conditions within the U.S. market. The company's key product is Afrezza, an inhaled insulin designed to improve glycemic control for adults managing diabetes. MannKind also actively...

Can you invest in MannKind Corporation?

Yes. MannKind Corporation is publicly traded on NASDAQ under the ticker MNKD.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for MannKind Corporation

Detailed equity research is provided by MarketSnap.